On today's Easter stock picking fest, I was delighted to speak to accomplished investor John Hugham of Vox Markets
Genedrive reports strong revenue growth, narrowed operating loss, and significant operational progress for its lead assets MT-RNR1 and CYP2C19.
Revolution Beauty delivers strong trading in FY24, surpassing previous expectations amid a new strategy to accelerate growth. The group upgraded its profit guidance to £11-12m and sales guidance to low single digits. REVB shares jumped 9% on the news.
CleanTech Lithium comments on the Chilean government's recent designation of strategic and protected salars.
Kromek Group, a developer of radiation and bio-detection technology, has announced a significant $2.1m order from a US-based OEM customer in the homeland security sector for key detector components. The contract adds to Kromek's growing FY25 pipeline, helping deliver another year of growth.
In this interview, 1st class fund manager Richard Penny of Crux Asset Management takes Vox Markets 16 stocks.
Fintel announces two strategic investments aimed at enhancing its IP, scale, and product suite: a distribution agreement and minority investment in Mortgage Brain, a key technology provider to the mortgage industry; and the acquisition of 70% of ifaDASH, a reg-tech solution for intermediaries.
i3 Energy Canada announces its 2023 year-end reserves, maintaining stable volumes despite restrained capex amid declining commodity prices.
88 Energy's flow test of Hickory-1 is approaching the halfway mark with the Upper SFS portion nearly complete. The discovery well is located within 88E's flagship Project Phoenix on Alaska's North Slope, and aims to assess 647 million barrels of prospective oil resources.
On today's live ‘Exchange’, I was delighted to speak to accomplished investor & trader Michael Taylor of Shiftingshares.com
Explore how Good Life Plus is reshaping the prize draw landscape by seamlessly integrating membership benefits and entertainment. With rapid subscriber growth and a seasoned executive team, GDLF is poised for significant expansion over the next 24 months.
Silverbullet unveils contract wins and renewals valued at £1.7 million, solidifying partnerships with industry giants Heineken and Greene King.
Avacta's AVA6000 emerges as a beacon of hope in cancer treatment, as its Phase 1a trial showcases remarkable advancements in precision therapy.
Strategic Minerals announces a landmark agreement with the Duchy of Cornwall, securing exclusive mineral rights in the Tamar Valley region and quadrupling its footprint in the area.
CleanTech Lithium has commenced operations at its pilot plant in Chile, successfully producing lithium chloride eluate through Direct Lithium Extraction (DLE), marking a significant milestone for the company.
Vox Markets speaks to Ilian Iliev, CEO of deep tech and life science VC investor NetScientific, about the company's deep experience and unique approach to unlocking value from bleeding edge technologies.
Trading continues to be strong with YTD’24 turnover reported to be up 28% YoY to £22.2m (vs £17.4m LY) thanks to improving revenues/day, 1st sales from Europe and “particularly strong growth from Solutions” which target larger corporates.
Poolbeg Pharma bolsters its IP portfolio with the receipt of a Notice of Allowance from the US Patent Office for a significant POLB 001 patent. The development underscores the potential of POLB 001 as a breakthrough therapy for hypercytokinaemia.
Today, Alastair Ford interviews Neil Herbert from Atlantic Lithium, discussing recent announcements and the company's progress.
Mpac Group reports substantial revenue and profit growth in FY23 in line with market expectations.